Source: Amgen, Flickr.The biotech sector is something of a roulette wheel for investors. The chances of being right are typically against you, but if you can land a winner every now and then the rewards can multiply many times over your initial bet.A majority of the biotech sector is comprised of clinical-stage pipelines or developing product portfolios which are still […]
Source: “11g poker chips” by Logan Ingalls from South Boston, MA, USA. Licensed under CC BY 2.0 via Wikimedia CommonsGive up now if you’re looking for a totally safe biotech stock. They don’t exist.But if you’re looking for a biotech stock that is relatively safe compared to most others, that’s a different story. And there’s one biotech that is arguably the […]
Momentum Stocks: Caution Ahead (Part 4 of 6)(Continued from Part 3)Another case in point is biotech.Biotech is another obvious example of the momentum trade. It is a high “beta” or risky industry that has been a strong relative performer for many years. Through the close of the week ended March 20, the Nasdaq Biotech Index had surged 20% year-to-date. The following […]
Weakness in healthcare, industrial and energy shares dragged benchmarks significantly lower on Tuesday. The energy sector took a beating after oil prices dropped. Yesterday’s decline pulled the Dow into the red for the quarter, while S&P 500 managed meager gains.For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street articleThe Dow […]
Benchmarks ended the last trading session of the week on a positive note after Fed Chair Janet Yellen said there was a possibility of a gradual hike in interest rates sometime this year. The Nasdaq was boosted by a possible deal between Intel and Altera. Gains in bio-tech stocks also helped the Nasdaq end in positive territory. However, benchmarks reported […]
Biotech bubble may just be an optical illusion
By iCELL News on March 27, 2015 · Sector
SAN FRANCISCO (MarketWatch)—The stellar performance of biotechnology stocks in the past few years has predictably sparked fears of an impending crash. But for all the talk of a bubble, biotechs are far from being overbought, according to analysts at Credit Suisse.“There are optics suggesting that […]
Short interest has risen in a number of biotech names perceived as vulnerable to a selloff after a rally that has sent the Nasdaq Biotechnology Index <.NBI> up 42 percent over the last year even after this week’s declines.Overall, a screen of about 1,650 mid-cap U.S. companies shows biotech stocks, on average, have a short interest ratio of about 11.6 […]
Wikimedia CommonsSee AlsoAviation tracking service: Germanwings co-pilot set autopilot to the lowest possible settingFed market gurus prep rate hike amid last-minute anxietiesWe just found out who the third American was on the crashed Germanwings flightNEW YORK (Reuters) – A 4 percent decline in biotechnology stocks on Wednesday sent the Nasdaq Composite Index to its largest one-day loss in nearly a […]
Related CELGIs It Closing Time At The Biotech Bar?Weekly Options Outlook: Bulls Leave Money On The Table Despite A Week-End WinCelgene backs away from development of mAb for blood cancer(Seeking Alpha)Related ILMNIs It Closing Time At The Biotech Bar?3 Niche ETFs Breaking Out3 Excellent Biotech Stocks to Buy on the Dip – Stocks in the News(Zacks)By and large, the short […]
Last summer, Federal Reserve Chair Janet Yellen said valuations in certain corners of the stock market like biotech were getting “substantially stretched,” and traders have gotten a good laugh at her warning ever since as the stocks resumed their winning ways and raced higher. But given the recent battering of the biotech stocks, the caution recommended by the central bank […]
